Lucine

About:

Lucine has the ambition to transform and improve patient’s health.

Website: https://lucine.fr

Twitter/X: lucinegroup

Top Investors: Bpifrance, EASME - EU Executive Agency for SMEs, Kurma Partners, BNP Paribas Développement, IRDI SORIDEC Gestion

Description:

Lucine has the ambition to transform and improve patient’s health. Their main therapeutic area is pain. The product, a digital therapeutic is able to relieve patient’s pain in 5 minutes through active substances allowing an analgesic neurostimulation. Customized, their solution is adapted to each patient thanks to an instantaneous measurement and analysis of the pain by facial, vocal and postural recognition.

Total Funding Amount:

5.57M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Bordeaux, Aquitaine, France

Founded Date:

2017-01-01

Contact Email:

contact(AT)lucine.io

Founders:

Amine Marouf, Aymeric Esperance, Maryne Cotty-Eslous

Number of Employees:

11-50

Last Funding Date:

2020-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai